What is the treatment for postpartum chorioamnionitis in a patient after delivery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postpartum Chorioamnionitis Treatment

Primary Recommendation

For postpartum chorioamnionitis after vaginal delivery, administer a single additional dose of the antibiotics used intrapartum (ampicillin plus gentamicin), then discontinue; for cesarean delivery, add clindamycin at cord clamping and give one additional dose postpartum. 1, 2

Antibiotic Regimen

Intrapartum Treatment (Continued Postpartum)

  • Ampicillin 2 grams IV every 6 hours plus gentamicin is the first-line regimen for chorioamnionitis treatment 2, 3
  • Gentamicin can be dosed either:
    • Daily dosing at 5 mg/kg ideal body weight (preferred - associated with 64% lower risk of postpartum endometritis and 5% greater chance of successful outcome) 4
    • Traditional dosing at 1.5 mg/kg every 8 hours 1, 2

Cesarean Delivery Addition

  • Add clindamycin 900 mg IV at umbilical cord clamping if delivery is by cesarean section 5, 1, 2
  • This provides additional anaerobic coverage for the surgical procedure 6

Duration of Postpartum Therapy

After Vaginal Delivery

  • One additional scheduled dose of ampicillin and gentamicin after delivery is sufficient 1
  • A landmark randomized trial of 292 women demonstrated no difference in treatment failure rates between single additional dose (4.6% failure) versus continuing antibiotics until afebrile for 24 hours (3.5% failure) 1
  • Discontinue antibiotics after this single dose unless treatment failure occurs 1, 2

After Cesarean Delivery

  • One additional dose of the three-drug regimen (ampicillin, gentamicin, clindamycin) after delivery 1, 2
  • Alternative approach: single 2-gram dose of cefotetan postpartum (11% failure rate, decreases hospital stay by 24 hours) 7

Treatment Failure Management

Definition of Treatment Failure

  • Single temperature ≥39.0°C after first postpartum antibiotic dose 1
  • Two temperatures ≥38.4°C at least 4 hours apart 1

Management of Treatment Failure

  • Resume broad-spectrum antibiotics and continue until afebrile and asymptomatic for 24 hours 1
  • Consider broader coverage with agents active against resistant organisms 5
  • Obtain cultures to guide therapy adjustment 6

Penicillin Allergy Considerations

Non-Severe Allergy

  • Cefazolin is the preferred alternative for patients without history of anaphylaxis, angioedema, respiratory distress, or urticaria 5

Severe Allergy

  • Clindamycin or vancomycin should replace ampicillin 5
  • Maintain gentamicin for gram-negative coverage 5

Neonatal Implications

Mandatory Neonatal Evaluation

  • All newborns born to mothers with chorioamnionitis require limited evaluation: blood culture and complete blood count with differential and platelet count 5, 8
  • CBC sensitivity improves if delayed 6-12 hours after birth 5
  • Neonates should receive empiric antibiotics pending culture results: ampicillin plus gentamicin or cefotaxime for gram-negative and GBS coverage 9, 5

Critical Pitfalls

  • Do not delay delivery to complete antibiotic course - delivery is essential for cure, as antibiotics alone cannot eradicate chorioamnionitis 2, 3
  • Do not routinely continue prolonged postpartum antibiotics - this increases cost and hospital stay without improving outcomes in immune-competent women 1, 2
  • Do not forget clindamycin at cesarean delivery - anaerobic coverage is critical for surgical site infection prevention 5, 1
  • Monitor renal function if using aminoglycosides, especially with higher doses or prolonged therapy, due to nephrotoxicity and ototoxicity risk 6

References

Research

Management of clinical chorioamnionitis: an evidence-based approach.

American journal of obstetrics and gynecology, 2020

Research

Clinical chorioamnionitis: where do we stand now?

Frontiers in medicine, 2023

Research

Daily gentamicin using ideal body weight demonstrates lower risk of postpartum endometritis and increased chance of successful outcome compared with traditional 8-hour dosing for the treatment of intrapartum chorioamnionitis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019

Guideline

Management of Chorioamnionitis Before Delivery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Chorioamnionitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.